OH2 Injection in Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
- Status
- RECRUITING
- Phase
- NA
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Status
- RECRUITING
- Phase
- NA
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
'Cancer Patients Better Life Experience'
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
- Status
- TERMINATED
- Phase
- N/A
TRAQinform Assessment of Immunotherapy Response
- Status
- COMPLETED
- Phase
- N/A
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations
- Status
- COMPLETED
- Phase
- PHASE1
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3